The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Discover proven strategies to grow small investments. Learn how to make the most of your financial resources effectively.
19,213 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Seeing a neighbor's Social Security check grow while yours stays the same can feel frustrating. This guide explains t...
The stock market has shown impressive strength, but political forces and monetary policy tensions can tilt the landsc...
SpaceX headlines are loud, but IPOs are not always friendly to investors. This article outlines seven solid reasons a...
Struggling with multiple debts and high payments? Quick debt consolidation can streamline bills, lower your monthly o...
A single bullish call can spark excitement, but savvy investors know that big upside ideas demand rigorous scrutiny. ...
Investors woke to a drop in first majestic silver stock as metal prices wavered and costs rose. This guide breaks dow...
When a fresh, original film hits the top spot, it isn’t just a movie moment—it’s a money moment. This article breaks ...
As tax season kicks off, the IRS unveils its 2026 Dirty Dozen and warns taxpayers about increasingly sophisticated sc...
A security firm reports that researchers used Claude Mythos AI to help build a macOS kernel exploit. The incident spo...
SpaceX reportedly trims its IPO ambitions, signaling a lower target valuation looming. This article breaks down what ...
SpaceX may be the headline grabber, but buying on day one isn’t a slam-dunk. This guide gives you three essential que...